EXECUTIVE TEAM


ZOË BARRY, FOUNDER & CEO

FOUNDER AND CEO

SANDY DICESARE

CHIEF OPERATING OFFICER

Mary Hirtle Web (2 of 2)

ACTING CFO

jon-web-1

ASSOCIATE GENERAL COUNSEL

ZeeshanKhan

VP, PRODUCT DEVELOPMENT

Hans Oh Web (2 of 3)

VP, CORPORATE STRATEGY AND DEVELOPMENT

richkramer-web

VP, COMMERCIAL OPERATIONS

BOARD OF DIRECTORS


Jill Carroll_v2

PRINCIPAL, SR ONE

Gary Rieschel

FOUNDING MANAGING PARTNER, QIMING

KRISHNA YESHWANT

PARTNER, GV (BOARD OBSERVER)

KEVIN BITTERMAN

PARTNER, ATLAS VENTURE (BOARD OBSERVER)

Nancy Lieberman21440x600px72dpi

BOARD MEMBER (ZAPPRX) FORMER PARTNER OF SKADDEN ARPS

ADVISORS


PETER WIRTH

ADVISOR

JEREMY LEVIN

ADVISOR

SIMON KENNEDY

ADVISOR

SCOTT MCKAY

ADVISOR

john-musil_v3

ADVISOR

JEFF BERKOWITZ

ADVISOR

Competitive analysis

    • How many prescriptions were written for my brand? Other brands? By whom?

    • How many prescriptions were filled? Refilled?

    • Am I missing fills from when patients change insurance?


Time to Fill (TTF)

    • How quickly are my scripts being filled?

    • What and where are the bottlenecks?

    • What are payers doing to impact access? Pricing?


Real-world evidence

    • When, how, and why does my drug work?

    • What patients, biomarkers, and companion diagnoses predict performance?

    • How many prescriptions were abandoned by patients? Why?